Search results
Rs 85 crore
- Pathology company Dr Lal PathLabs Limited on May 10 reported 52 percent jump in consolidated net profit at Rs 85 crore for the quarter ended 31 March, 2024. The company had reported a net profit of Rs 56 crore in the year-ago period. Revenue from operations increased 11 percent to Rs 545 crore from Rs 491 crore in the said quarter.
People also ask
How much revenue did Dr Lal PathLabs Limited generate in Q4 FY 2022-23?
How did Dr Lal PathLabs perform in the third quarter of 2021?
How many shares were traded for Dr Lal PathLabs?
Results for Quarter ended September 30, 2021. Press Release. Press Release Q2 FY 2022. Earnings Presentation. Earning Presentation Q2 FY 2022. Unaudited Financial Results. Unaudited Financial Result-Q2 FY 2022.
- Quarterly Results
Quarterly Results - Quarterly Results - Dr Lal PathLabs
- Letters of Appointment
Letters of Appointment - Quarterly Results - Dr Lal PathLabs
- Corporate Presentation
Corporate Presentation - Quarterly Results - Dr Lal PathLabs
- Policies and Programs
Policies and Programs - Quarterly Results - Dr Lal PathLabs
- Schedule a Radiology Appointment
How many labs and centres does Dr Lal PathLabs have at...
- Contact Us
Dr Lal PathLabs Ltd. Regd. Office: Block E, Sector -18,...
- Franchisee Login
© 2016 Dr Lal PathLabs. All Rights Reserved. Blog | Terms of...
- Newsletters
Newsletters - Quarterly Results - Dr Lal PathLabs
- Quarterly Results
Get Dr Lal PathLabs latest Quarterly Results, Financial Statements and Dr Lal PathLabs detailed profit and loss accounts.
Dr Lal Pathlabs Quarterly results. BSE: 539524 | NSE: LALPATHLABEQ | IND: Diagnostics | ISIN code: INE600L01024 | SECT: Hospitals & Allied Services. The Quarterly Results page of Dr. Lal Pathlabs Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results. TOTAL INCOME. 13.78 % Rs 563.30Cr.
Quarterly & Annual Financial Results of Dr Lal Pathlabs Ltd Check latest quarterly results and compare financial performance over past years. Get latest Standalone, Consolidated and Segment wise financial results.
Jul 28, 2022 · Financial results of the Company are best monitored on a year to date basis, as there is a certain level of seasonality in business and specific quarter performance may be influenced by certain occurrences in that quarter
Dr Lal PathLabs Limited records revenue of Rs 491 Cr in Q4 FY 2022-23. New Delhi, India, May 11, 2023 – Dr Lal PathLabs Limited (referred to as the “Company”; NSE: LALPATHLAB, BSE: 539524), a leading diagnostic and related healthcare service provider announces their financial results for the quarter ended March 31, 2023. .
May 10, 2024 · Pathology company Dr Lal PathLabs Limited on May 10 reported 52 percent jump in consolidated net profit at Rs 85 crore for the quarter ended 31 March, 2024.